G. Solladié et al. / Tetrahedron: Asymmetry 10 (1999) 2739–2747
2745
1
identical. H NMR (CDCl3): δ 1.98 (s, 3H, 30-CH3), 2.40 (s, 3H, Me p-Tol), 3.90 (s, 3H, OMe), 3.92
(s, 3H, OMe), 4.54 (AB, 2H, J=14 Hz, ∆ν=85 Hz, H-2), 5.94 (s, 1H, H-50), 7.43 (A2B2, 4H, J=8 Hz,
∆ν=53 Hz, ArH), 13.17 (s, 1H, 20-OH); 13C NMR (CDCl3): δ 7.2 (50-Me), 21.5 (Me p-Tol), 55.7, 55.8
(OMe), 72.2 (C-2), 86.0 (C-50), 105.6, 106.2 (C-10, C-30), 124.5, 130.0 (Cart), 141.0, 141.9 (Carq), 161.3,
163.9, 164.8 (C-20, C-40, C-60), 194.2 (C-1); IR (CHCl3): νmax (cm−1) 3960, 3920, 2990, 2400, 1630,
1600, 1495, 1470, 1410, 1290, 1145, 1090, 1035, 1015, 940. Anal. calcd for C18H20O5S: C, 62.05; H,
5.79. Found: C, 62.14; H, 5.62.
1.8. 5,7-Dimethoxy-8-methylflavone 11
To a solution of ketosulfoxide 9 (55 mg, 0.158 mmol, 1.0 equiv.) in CH2Cl2 (2 ml) was added 0.4
ml of a solution prepared from benzaldehyde (1.0 ml, 9.8 mmol), pyrrolidine (0.1 ml, 1.2 mmol) and
CH2Cl2 (4 ml). The solution was stirred for 22 h before being evaporated to dryness. A mixture of
hexane:AcOEt (1:1, 5 ml) was added and the solid product was filtered to give 27 mg (yield 58%) of 11.
The crude product was crystallized from ethanol (1.4 ml) to give fine white needles. Rf≈0.05 (AcOEt;
1
anisaldehyde: yellow); mp=228–229°C (lit.13: 230–232°C); H NMR (CDCl3): δ 2.33 (s, 3H, 8-Me),
3.95, 4.00 (2s, 6H, 2×OMe), 6.42 (s, 1H, H-6), 6.67 (s, 1H, H-2), 7.5 (m, 3H, ArH), 7.9 (m, 2H, ArH);
13C NMR (CDCl3): δ 8.2 (8-Me), 55.9, 56.5 (OMe), 91.5 (C-6), 106.2, 108.4 (C-8, C-10), 126.0 (C-20,
C-60), 129.1 (C-30, C-50), 131.2 (C-40), 132.0 (C-10), 156.7, 159.1, 160.5, 161.4 (C-2, C-5, C-7, C-9),
178.4 (C-4).
1.9. (−)-(SS)-5,7-Dimethoxy-8-methyl-3-(p-tolylsulfinyl)chromen-4-one 12
A solution of LDA (14.9 mmol, 2.6 equiv.) was cannulated to a suspension of ketosulfoxide 9 (2.00 g,
5.75 mmol, 1.0 equiv.) in THF (25 ml) at −40°C, giving an orange solution. The temperature was then
allowed to reach −20°C (solution A). At the same time, 1-formyl-1H-imidazole was prepared in situ at
room temperature by adding formic acid (0.47 ml, 12.3 mmol, 2.13 equiv.; in 5 ml of THF) to a solution
of 1,10-carbonyldiimidazole (2.01 g, 12.4 mmol, 2.16 equiv.) in THF (15 ml) (solution B). Solution B
was added to solution A at −60°C and the mixture was allowed to reach room temperature. The solution
was stirred overnight before being quenched with 1 M sulfuric acid (15 ml). The organic solvents were
evaporated and the residue was taken up with CH2Cl2 and washed with brine. The organic phase was
dried, filtered and concentrated. The crude product was dissolved in CH2Cl2 (35 ml) and stirred in the
presence of silica gel (6 g) until disappearance of the intermediate product (2 h). This mixture was
poured onto a filled column of silica gel/CH2Cl2 and eluted with CH2Cl2:AcOEt (3:1) to give 1.490 g
(yield 72%) of 12. The product could be crystallized from AcOEt (25 ml) and CH2Cl2 (10 ml). Rf=0.42
(CH2Cl2:AcOEt, 1:1); Rf (intermediate product)=0.27 (CH2Cl2:AcOEt, 1:1); mp=223–225°C (fine white
needles); [α]D=−300 (c 1.0; CHCl3); 1H NMR (CDCl3): δ 2.19 (s, 3H, 8-CH3), 2.35 (s, 3H, Me p-Tol),
3.92, 3.93 (2s, 6H, 2×OMe), 6.37 (s, 1H, H-6), 7.51 (AB, 4H, J=8 Hz, ∆ν=108 Hz), 8.24 (s, 1H, H-2);
13C NMR (CDCl3): δ 7.8 (8-Me), 21.5 (Me p-Tol), 56.0, 56.4 (OMe), 92.0 (C-6), 106.5, 108.3 (C-8,
C-10), 125.7, 129.9 (Cart), 129.6 (C-3), 140.6, 142.0 (Carq), 152.8 (C-2), 156.8, 159.4, 162.1 (C-5, C-7,
C-9), 173.2 (C-4); IR (CHCl3): νmax (cm−1) 3690, 3620, 2990, 2400, 1645, 1610, 1585, 1500, 1470,
1435, 1395, 1340, 1315, 1270, 1145, 1125, 1080, 1035, 1015, 950, 920. Anal. calcd for C19H18O5S: C,
63.67; H, 5.06. Found: C, 63.69; H, 4.81.